Other Infections
HR17: Drug Checking Reveals High Levels of Fentanyl Contamination
- Details
- Category: Drug Use and Harm Reduction
- Published on Tuesday, 16 May 2017 00:00
- Written by Liz Highleyman
A pilot project to check the purity of drugs at Vancouver's Insite safe injection facility found that around 80% of tested samples contained fentanyl, and people who learned their drugs were contaminated were more likely to reduce their doses and less likely to overdose, researchers reported at the 25th Harm Reduction International Conference this week in Montreal.
HR17: Hydromorphone Works as Well as Heroin-Assisted Drug Addiction Treatment
- Details
- Category: Drug Use and Harm Reduction
- Published on Tuesday, 16 May 2017 00:00
- Written by Liz Highleyman
Hydromorphone was as effective as pharmaceutical heroin for opioid addiction treatment, but it was associated with fewer serious side effects, according to results from the SALOME trial presented at the 25th Harm Reduction International Conference this week in Montreal.
CROI 2017: Prednisone Reduces Risk of Developing TB-IRIS after Starting Antiretroviral Treatment
- Details
- Category: Tuberculosis (TB)
- Published on Wednesday, 08 March 2017 00:00
- Written by Keith Alcorn
Prednisone reduces the risk of immune restoration inflammatory syndrome (IRIS) in people with HIV after starting tuberculosis (TB) treatment, a randomized trial called PredART has found. The results were presented last month at the Conference on Retroviruses and Opportunistic Infections in Seattle by Graeme Meintjes from the University of Cape Town in South Africa.
HR17: AA Amyloidosis Is an Unrecognized Problem Among People Who Inject Drugs
- Details
- Category: Drug Use and Harm Reduction
- Published on Tuesday, 16 May 2017 00:00
- Written by Liz Highleyman
AA amyloidosis, a condition resulting from skin and soft tissue infections that can lead to kidney failure, may be more common than previously recognized among people who inject drugs, according to a presentation at the 25th Harm Reduction International Conference this week in Montreal.
CROI 2017: Isoniazid Preventive Therapy for TB Reduces Risk of Death for People Living with HIV
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 28 February 2017 00:00
- Written by Keith Alcorn
A 6-month course of isoniazid preventive treatment (IPT) for at the beginning of the Temprano trial in Ivory Coast reduced the risk of death by 37% over a mean follow-up period of 4.5 years, Anani Badje reported at the Conference on Retroviruses and Opportunistic Infections this month in Seattle.
PAS 2017: Vaccine Reduces Human Papillomavirus Prevalence Among Young Women
- Details
- Category: HPV Vaccines
- Published on Tuesday, 16 May 2017 00:00
- Written by Liz Highleyman
The prevalence of human papillomavirus (HPV) types included in the most widely used vaccine has decreased among adolescent and young women in the U.S., with "herd immunity" extending to those who were not vaccinated themselves, according to study results presented at the Pediatric Academic Societies Meeting last week in San Francisco.
CROI 2017: Triple Tuberculosis Regimen Beats XDR-TB in First Trial
- Details
- Category: Tuberculosis (TB)
- Published on Monday, 20 February 2017 00:00
- Written by Keith Alcorn
A regimen of three oral drugs given for 6 months was enough to clear extensively drug-resistant tuberculosis (XDR-TB) in 29 of the first 31 people to have completed the treatment course, Francesca Conradie of Sizwe Tropical Disease Hospital in Johannesburg reported at the 2017 Conference on Retroviruses and Opportunistic Infections last week in Seattle. If the results are replicated in a larger population, the findings could revolutionize the prospects for treating not just XDR-TB, but also more severe cases of multidrug-resistant tuberculosis (MDR-TB).
EASL 2017: Norfloxacin Reduces Risk of Death for People with Decompensated Cirrhosis
- Details
- Category: Liver Decompensation
- Published on Saturday, 22 April 2017 00:00
- Written by Keith Alcorn
Long-term prophylaxis with the antibiotic norfloxacin significantly reduced the incidence of death in people with decompensated cirrhosis over a 6-month follow-up period, according to a French randomized trial reported at the EASL International Liver Congress this week in Amsterdam.
10. Not Enough Syringe Programs for People Who Inject Drugs
- Details
- Category: Drug Use and Harm Reduction
- Published on Thursday, 22 December 2016 00:00
- Written by HIVandHepatitis.com
The opioid epidemic in the U.S. -- with its attendant risk of overdose and HIV and viral hepatitis transmission -- remained a concern in 2016, with new data showing that many people who inject drugs do not have consistent access to sterile syringes.
More Articles...
- 27 Million People in U.S. Use Illicit Drugs, Harm Reduction Not Keeping Pace
- AASLD 2016: When You Eat May Contribute to Fatty Liver Disease as Much as What You Eat
- Young Adolescents Need Only 2 Doses of Human Papillomavirus Vaccine, CDC Says
- IDWeek 2016: Rapid Emergence of Drug-Resistant Gonorrhea Seen in Ohio
- Sexually Transmitted Disease Rates Hit New Highs, CDC Report Says
Web Design and Development by